Cargando…

Differential Expression of Genes Involved in Metabolism and Immune Response in Diffuse and Intestinal Gastric Cancers, a Pilot Ptudy

Gastric cancer (GC) is one of the major causes of cancer-related mortality worldwide. The vast majority of GC cases are adenocarcinomas including intestinal and diffuse GC. The incidence of diffuse GCs, often associated with poor overall survival, has constantly increased in USA and Europe The molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrot-Applanat, Martine, Pimpie, Cynthia, Vacher, Sophie, Bieche, Ivan, Pocard, Marc, Baud, Véronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869420/ https://www.ncbi.nlm.nih.gov/pubmed/35203450 http://dx.doi.org/10.3390/biomedicines10020240

Ejemplares similares

Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer
por: Perrot-Applanat, Martine, et al.
Publicado: (2019)

Detection of Persistent Organic Pollutants in Omental Adipose Tissue from Patients with Diffuse-Gastric Cancer: A Pilot Study
por: Perrot-Applanat, Martine, et al.
Publicado: (2021)

High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism
por: Vacher, Sophie, et al.
Publicado: (2018)

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics
por: Di Benedetto, Melanie, et al.
Publicado: (2015)

Similar NF-κB Gene Signatures in TNF-α Treated Human Endothelial Cells and Breast Tumor Biopsies
por: Perrot-Applanat, Martine, et al.
Publicado: (2011)

Mitosis in Cancer Cell Increases Immune Resistance via High Expression of HLA-G and PD-L1
por: Ullah, Matti, et al.
Publicado: (2020)

The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma
por: Shah, Shahid, et al.
Publicado: (2018)

Differentiation of cancer cells upregulates HLA-G and PD-L1
por: Ullah, Matti, et al.
Publicado: (2020)

Multi-nanolayer drug delivery using radiofrequency plasma technology
por: Al Dybiat, Iman, et al.
Publicado: (2020)

Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes
por: Becherirat, Selma, et al.
Publicado: (2018)

Magnetic Compression of Tumor Spheroids Increases Cell Proliferation In Vitro and Cancer Progression In Vivo
por: Mary, Gaëtan, et al.
Publicado: (2022)

Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients
por: Karam, Manale, et al.
Publicado: (2014)

NF-kappa B genes have a major role in Inflammatory Breast Cancer
por: Lerebours, Florence, et al.
Publicado: (2008)

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018)

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
por: Lallemand, François, et al.
Publicado: (2017)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

PIK3R1 underexpression is an independent prognostic marker in breast cancer
por: Cizkova, Magdalena, et al.
Publicado: (2013)

Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
por: Pavlovic, Mladen, et al.
Publicado: (2018)

Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway
por: Cizkova, Magdalena, et al.
Publicado: (2010)

Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients
por: Cabel, Luc, et al.
Publicado: (2019)

EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma
por: Shen, Wei-Wei, et al.
Publicado: (2020)

Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer
por: Singh, Smrita, et al.
Publicado: (2021)

Targeting the differentiation of gastric cancer cells (KATO-III) downregulates epithelial-mesenchymal and cancer stem cell markers
por: Shah, Shahid, et al.
Publicado: (2019)

Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas
por: Meseure, Didier, et al.
Publicado: (2020)

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
por: Tanaka, Iris, et al.
Publicado: (2020)

Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
por: Liang, Xu, et al.
Publicado: (2018)

Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar-Labarchède, Géraldine, et al.
Publicado: (2022)

Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar‑Labarchède, Géraldine, et al.
Publicado: (2022)

Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer
por: Tanabe, Shihori, et al.
Publicado: (2020)

MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
por: Laé, Marick, et al.
Publicado: (2016)

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
por: Cizkova, Magdalena, et al.
Publicado: (2012)

PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study
por: Eveno, Clarisse, et al.
Publicado: (2018)

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis
por: Dumortier, Mandy, et al.
Publicado: (2018)

Serum gastrin levels in patients with intestinal and diffuse type of gastric cancer.
por: Rakic, S., et al.
Publicado: (1991)

Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer
por: Jeong, Sang-Ho, et al.
Publicado: (2021)

PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
por: Pignot, Géraldine, et al.
Publicado: (2019)

Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951.
por: Lundegårdh, G., et al.
Publicado: (1991)

Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma
por: Tsantoulis, Petros, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o5dl5cgvkskr1n29lvmamq8k2l